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This document summarizes the findings of the recently released NIOSH
Criteria for a Recommend Standard Occupational Exposure to Metalworking
Fluids.  According to the Occupational Safety and Health Act of 1970 (Public
Law 95-164), the National Institute for Occupational Safety and Health (NIOSH)
is charged with recommending occupational safety and health standards and
describing exposure concentrations that are safe for various periods of employ-
ment–including but not limited to concentrations at which no worker will suffer
diminished health, functional capacity, or life expectancy as a result of his or her
work experience. The metalworking fluids criteria document provides the scien-
tific basis for NIOSH’s recommended occupational health standard for occupa-
tional exposure to metalworking fluids.  It contains a critical review of the scien-
tific and technical information available on the extent and type of health hazards
associated with metalworking fluids and the adequacy of control methods.
This document represents the first effort by NIOSH to develop simultaneously
both a companion educational document and a criteria document.  NIOSH uses
criteria documents to communicate these recommended standards to regulatory
agencies (including the Occupational Safety and Health Administration [OSHA])
and to others in the occupational safety and health community.  The companion
educational document is intended to communicate the basic information from the
criteria document to health professionals, industry, organized labor, public interest
groups, government agencies, and other interested groups or individuals.  We
encourage readers who are interested in examining in more detail the scientific
evidence on the health effects of metalworking fluids and the basis of the NIOSH
recommendations to review the criteria document.
Linda Rosenstock, M.D., M.P.H.
Director, National Institute for Occupational Safety Health




Section 1 - Introduction
For purposes of this document, metalworking fluids (MWFs) are fluids used
during machining and grinding to prolong the life of the tool, carry away debris,
and protect the surfaces of work pieces.  These fluids reduce friction between the
cutting tool and the work surface, reduce wear and galling, protect surface charac-
teristics, reduce surface adhesion or welding and carry away generated heat.
Workers can be exposed to MWFs by inhaling aerosols (mists) and by skin con-
tact with the fluid.  Skin contact occurs by dipping the hands into the fluid,
splashes, or handling workpieces coated with the fluids.  The amount of mist
generated (and the resulting level of exposure) depends on many factors: the type
of MWF and its application process; the MWF temperature; the specific machin-
ing or grinding operation; the presence of splash guarding;  and the effectiveness
of the ventilation system in capturing and removing the mist.
Substantial scientific evidence indicates that workers currently exposed to MWF
aerosols have an increased risk of respiratory [lung] and skin diseases.  These
health effects vary based on the type of MWF, route of exposure, concentration,
and length of exposure.
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1 NIOSH recommends the use of NIOSH method #0500 for the sampling and
analysis of MWF aerosols (mist).  In order to convert the total particulate mea-
surement into an equivalent thoracic particulate result, divide the total concentra-
tion by a correction factor of 1.25 (or other factor experimentally measured for
that operation) [conversion factor adapted by Baron from the data of Woskie et al.,
1994].  As a result, the REL of 0.4 mg/m3 thoracic particulate mass is equivalent
to a 0.5 mg/m3 total particulate mass.
To reduce the potential health risks associated with occupational exposures to
metalworking fluids (MWFs),  NIOSH recommends an exposure limit (REL) for
MWF aerosol of  0.4 mg/m3 for thoracic particulate mass (the portion of the
aerosol that penetrates below the larnyx in the respiratory system) as a
time-weighted average (TWA) concentration for up to 10 hours per day during a
40-hour work week.1  Because of the limited availability of thoracic samplers,
measurement of total particulate mass is an acceptable substitute (see footnote 1
for details).  The REL for total particulate mass is 0.5 mg/m3.
The REL of 0.4 mg/m3 is based on four major considerations:
• the adverse respiratory health effects of MWF exposure;
• the selection of an index for measuring MWF aerosol exposure;
• the universal applicability of the REL to all types of MWFs; and,
• the technological feasibility of the REL.
NIOSH also recommends the development and implementation of occupational
safety and health programs, engineering controls, fluid management and medical
monitoring to reduce MWF exposures.
These recommendations are intended to prevent or greatly reduce  respiratory
disorders causally associated with MWF exposure.  Whenever possible, reduce
MWF aerosol levels below 0.4 mg/m3 (thoracic particulate mass) because some
workers have developed work-related asthma or hypersensitivity pneumonitis at
MWF exposures below the NIOSH recommended exposure level.  It is also
important to limit exposure levels based on the association between some past
MWF exposures and various cancers and because the minimization of exposures
by skin contact helps prevent allergic and irritant skin disorders.
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Section 2 - Occupational Exposures to MWFs
There are four different classes of metalworking fluids.
Metalworking fluids are grouped into four major classes:
1. Straight oil (neat oil) MWFs are severely solvent-refined petroleum oils
(lubricant-base oils) or other animal, marine, vegetable, or synthetic oils
used singly or in combination and with or without additives.  Straight oils
are not designed to be diluted with water.
2. Soluble oil (emulsifiable oil) MWFs are combinations of 30% to 85%
severely refined lubricant-base oils and emulsifiers that may include other
performance additives.  Soluble oils are diluted with water at ratios of 1
part concentrate to 5B40 parts water.
3. Semisynthetic MWFs contain a lower amount of severely refined
lubricant-base oil in the concentrate (5% to 30%), a higher proportion of
emulsifiers, and 30% to 50% water.  The transparent concentrate is diluted
with 10 to 40 parts water.
4. Synthetic MWFs contain no petroleum oils and may be water soluble or
water dispersible.  The synthetic concentrate is diluted with 10 to 40 parts
water.
Occupational exposures to MWFs occur by inhalation and skin
contact.
During machining operations, MWF exposures can occur by inhalation and skin
contact.
• Skin contact usually occurs when the worker dips his/her hands into the
fluid, floods the machine, tool, or work, or handles parts, tools, and equip-
ment covered with fluid,  without the use of personal protective equipment
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such as gloves and aprons.  Skin contact can also results from fluid splash-
ing onto the worker from the machine if guarding is absent or inadequate.
• Inhalation exposures result from breathing MWF mist or aerosol.  The
severity of the exposure depends on a wide variety of factors.  In general,
the exposure will be higher if: the worker is in close proximity to the
machine,  the operation involves high tool speeds and deep cuts,  the
machine is not enclosed, or if ventilation equipment was improperly
selected or poorly maintained.  In addition,  high-pressure and/or excessive
fluid application, contamination of the fluid with tramp oils, and improper
fluid selection and maintenance will tend to result in higher exposures.
MWFs may contain potentially hazardous chemical ingredients,
additives, and contaminants.
Each MWF class consists of a wide variety of chemicals used in different combi-
nations and the risk these chemicals pose to workers may vary because of differ-
ent manufacturing processes, various degrees of refining, recycling, improperly
reclaimed chemicals, different degrees of chemical purity, and potential chemical
reactions between components.
Workers may be exposed to a variety of contaminants.
Exposure to hazardous contaminants in MWFs may present health risks to work-
ers. Contamination may occur from (1) process chemicals and ancillary lubricants
inadvertently introduced, (2) contaminants, metals, and alloys from parts being
machined, (3) water and cleaning agents used for routine housekeeping, and (4)
contaminants from other environmental sources at the worksite.  In addition,
bacterial and fungal contaminants may metabolize and degrade the MWFs to
hazardous end-products as well as produce endotoxins.
Workers may be exposed to microorganisms and hazardous end
products.
Water-based MWFs are excellent nutritional sources for many kinds of bacteria
and fungi. The predominant microbial species routinely recovered from MWFs
are virtually identical to those routinely recovered from natural water systems.
Anaerobic bacteria, specifically the sulfate reducers, may produce hydrogen
sulfide and other disagreeable and toxic gases.
Research suggests that microorganisms and/or their products such as endotoxins
may cause some of the respiratory health effects seen in exposed workers.  How-
ever, this research has not determined the specific role that the contaminating
microorganisms play in causing MWF associated respiratory effects.
At this time, insufficient health data exists to recommend a specific limit for
bacterial or fungal concentrations in contaminated MWFs.  However, their poten-
tial as health hazards for exposed workers must not be minimized.  A total MWF
system management program should be used to protect workers.  This program
should include:
• careful fluid monitoring, record keeping and maintenance;
• use of biocides only as a preventive measure and not for the cure of microbial
overgrowth;
• a system of mist control including close-capture ventilation, and machine
enclosures; and
• training for employees on the hazards and proper use of the MWFs.
The improper use of biocides to manage microbial growth may
result in potential health risks.
Attempts to manage microbial growth solely by the incorporation or addition of
biocides may result in the emergence of biocide-resistant strains from complex
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interactions that may occur among different member species or groups within the
population.  For example, the growth of one species may result in conditions more
(or less) favorable for the establishment of future species, or the elimination of
one group of organisms may permit the overgrowth of another.  Studies also
suggest that exposure to certain biocides can cause either allergic or contact
dermatitis.
Occupational exposures to MWFs cause potential health risks,
including: dermatological (skin) disorders, and lung disease.
NIOSH has conducted more than 70 on site Health Hazard Evaluations (HHEs) of
industries with occupational exposures to MWFs or mineral oil aerosols.  Ex-
posed workers most often reported skin disorders (skin irritation, rashes, oil acne)
followed by eye, nose, and throat irritation, and respiratory symptoms or disorders
(breathing problems, cough, chest tightness, asthma).
Dermatological Conditions:
Workers potentially exposed to MWFs suffer a high rate of skin diseases.  In
1991, the list of industries with the highest incidence rates for skin disorders (e.g.
fabricated, screw machine products, and general industrial machinery) all in-
volved potential MWF exposure.
Several different skin diseases can result from skin contact with MWFs.   In
general, reports link straight MWFs to folliculitis, oil acne, and keratoses; and
soluble, semisynthetic and synthetic MWFs with irritant contact dermatitis and
less frequently with allergic contact dermatitis.
Contact dermatitis (either irritant contact dermatitis or allergic contact dermatitis)
is the most commonly reported skin disease associated with MWFs.  The high
prevalence of dermatitis rates indicates the susceptibility of many workers to the
irritating or sensitizing nature of MWFs and contaminants.  Despite the high
reporting rate, many workers continue to work even with skin lesions and consid-
erable discomfort from burning and itching.  Some of these workers eventually are
disabled as a result of their skin disorders.
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Many factors play a role in the development of contact dermatitis and other skin
diseases in workers exposed to MWFs.  These factors include:
• the MWF class and additives used;
• the amount of skin contact with MWFs (e.g., through splashing or re-
peated or prolonged immersion);
• skin abrasion or cuts;
• individual susceptibility to irritants or allergens present in MWFs;
• inadequate cleansing of the skin after skin contact;
• the irritant nature of some soaps/detergents and other cleansing materials
used by the workers;
• reuse of MWF-soaked clothing and other materials;
• use of personal protective equipment such as face shields, clean and
nonirritating/nonsensitizing gloves and aprons;
• the cleanliness of the general work environment;
• climate (high or low humidity and hot, warm, or cold temperatures);
• machine types and operations, and engineering control methods (e.g.,
especially tight fitting machine enclosures) in place and in use.
Dermatitis prevention is important because of the poor prognosis for workers with
MWF dermatitis and because worker protection and engineering controls can
achieve primary prevention by limiting dermal exposure to MWFs.  Other preven-
tive measures include:
• substitution of safe, less irritating or nonallergenic additives or MWF
constituents;
• process modification and isolation to limit the dispersal of MWFs;
• work practice and administrative controls to assure the proper MWF
maintenance and workplace cleanliness;
• the proper use of personal protective equipment such as protective gloves,
aprons, and clothing; and
• the education of the workers regarding dermal effects due MWF contact,
and the importance of workplace personal hygiene.
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Cancer
Substantial evidence indicates that some MWFs are associated with an increased
risk of larynx, rectum, pancreas, skin, scrotum, and bladder cancer.  Because the
time between initial exposure to a carcinogen and the appearance of most types of
cancer is often 20 or more years, these studies most likely reflect the cancer risk
associated with exposure conditions in the mid-1970s and earlier.  It should be
noted that the studies results were not highly consistent with respect to the spe-
cific types of cancer which were associated with MWF.  In addition, the specific
MWF constituent(s) or contaminant(s) responsible for the various cancers remain
to be determined. The inconsistencies in the results, and the inability to identify
the responsible MWF constituent(s) or contaminant are a likely result of the
diverse nature of the MWF mixtures studied, and the absence of detailed exposure
information.
Over the last several decades, the metalworking industry has made substantial
changes including changes in MWF composition and reduction in MWF impuri-
ties and exposure concentrations.  Efforts have been made to reduce potentially
carcinogenic MWF additives and impurities with the removal of polynuclear
aromatic hydrocarbons (PAHs) from MWFs beginning in the 1950s, and the EPA
enacting regulations in the 1980s directed at reducing nitrosamine exposures.  It is
likely that the changes have reduced the cancer risks, but the data are insufficient
to conclude that these changes have eliminated all cancer risks.  Thus, the risk of
cancer from MWF exposures later than the mid-1970s remains to be determined.
However, both the substantial evidence which associates some MWFs used before
the mid-1970s with cancer at several organ sites, and the potential for current
MWFs to pose a similar carcinogenic hazard supports the NIOSH recommenda-
tion to reduce MWF aerosol exposures.
Lung Disease:
The primary basis for the NIOSH recommendation is the risk that MWFs pose for
nonmalignant respiratory disease.  Occupational exposure to MWF aerosols may
cause a variety of  respiratory conditions, including lipid pneumonia, hypersensi-
tivity pneumonitis, asthma, acute airways irritation, chronic bronchitis, and im-
paired lung function.  While, the most diseases of the deep lung–lipid pneumonia,
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hard metal disease, and legionellosis–appear relatively unusual in workers ex-
posed to MWF aerosols, hypersensitivity pneumonitis is recently emerging as an
important risk among workers exposed to MWF aerosol; and substantial evidence
indicates that workers currently exposed to MWF aerosols have an elevated risk
of airways disorders, including asthma.
MWF-Induced Asthma
Workers exposed to synthetic, soluble and straight MWFs have an increased risk
of work-related asthma, as seen below:
Synthetic MWFs - In one study the adjusted risk estimate for workers ex-
posed to synthetic MWF aerosol was about three times the risk relative for
unexposed workers.  Risk estimates were elevated in all three studies of
asthma and exposure to synthetic MWF aerosol, although the finding in one
study was not statistically significant.
Soluble MWFs - The evidence associating asthma and exposure to soluble oil
MWF aerosol is somewhat less consistent than that for synthetic MWFs, but
more studies have investigated this relationship. Only two studies presented
elevated risk estimates that were statistically significant, but five of the seven
epidemiologic studies of soluble oil MWF exposures reported elevated risk
estimates for asthma, with point estimates ranging upward from 1.7.  Overall,
the preponderance of evidence associated asthma with exposure to soluble oil
MWF aerosol.
Straight MWFs  - The epidemiologic evidence for an association between
asthma and exposure to straight oil MWF aerosol is less convincing than that
for synthetic and soluble oil MWFs.  None of the five studies of straight oil
MWFs documented a significantly increased risk, one did not include an
unexposed group necessary to derive a risk estimate, and two of the other four
studies did have a nonsignificant elevated risk.  Some clinical case reports
suggest that asthma is associated with exposure to straight oil MWF aerosol or
to compounds commonly found in straight oil MWFs. Overall, the risk of
asthma exists but is likely to be lower with exposure to straight oil MWF
aerosol than with exposure to aerosol from other classes of MWFs.
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MWF-induced asthma appears to involve known sensitizers in some cases but
various other agents (possibly acting through irritant or inflammatory mecha-
nisms) may cause a high proportion of cases.  These sensitizers and irritants
include ethanolamine and other amines, colophony, pine oil, tall oil, metals and
metallic salts (e.g., chromium, nickel), castor oil, formaldehyde, chlorine, various
acids, and microbial contaminants including Gram-negative bacterial endotoxin.
Studies of acute drops in lung function over a work shift also provide evidence
that exposure to MWF aerosol is associated with asthma.  In three of four perti-
nent studies, workers were more likely to experience acute loss of lung function as
the level of exposure to MWF aerosol increased.
Respiratory Effects Other Than Asthma
Studies of lung function provide some evidence that MWF aerosol exposure can
also cause an adverse chronic effect.  Overall, this evidence provides limited
support for associating MWF aerosol exposures above the REL with a chronic
reduction in lung function.  More convincing, all but one of the ten studies of
symptoms provide consistent and compelling evidence that occupational exposure
to MWF aerosol, for each class of MWFs (straight, soluble, and synthetic) and at
concentrations at or above the REL, causes chronic respiratory symptoms.  Cur-
rently, no clear evidence identifies any component(s) of MWF aerosol as the
predominant cause of these symptoms.
In addition to work-related asthma and chronic airway effects, recent outbreaks of
hypersensitivity pneumonitis [HP] have been associated with exposure to aerosols
of synthetic, semisynthetic, and soluble oil MWFs (all of which are water-based
or diluted with large amounts of water) at concentrations both above and below
the REL.   Microbial contaminants in MWFs are postulated to be the most likely
cause of these HP outbreaks.  Some workers with HP have been able to return to
jobs that involve no MWF exposure or to jobs that involve exposure to a different
MWF.  It is not clear whether reducing MWF aerosol exposure concentrations
























Reducing MWF exposures to concentrations below the REL,
whenever feasible, should decrease the number of new cases of
MWF-related asthma and the risk of chronic airways disease in
exposed working populations.
Based on the evidence of increased asthma risk in some studies and the clearly
increased risk of respiratory symptoms and acute lung function changes with
exposures above the REL, reducing MWF exposures to concentrations below the
REL, whenever feasible, should decrease the number of new cases of
MWF-related asthma in exposed working populations.  The prevention of asthma
is an important priority because, although clinical asthma may be mild in many
affected workers, it can sometimes be debilitating.  Occupational asthma fre-
quently persists as a chronic condition even after affected workers are removed
from exposure.  NIOSH is concerned that the same may be true for MWF-related
asthma.
Reducing MWF exposures should also decrease the risk of chronic airways
disease.  Repeated, modest acute airways effects from chronic exposure to MWF
aerosol–though apparently reversible when workers are removed from exposure–
may ultimately lead to irreversible impairment and chronic pulmonary disability.
Numerous studies link acute effects and chronic lung impairment for a variety of
other occupational respiratory hazards.  Although no studies have attempted to
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relate acute decrements caused by MWF aerosols with chronic airways obstruc-
tion among exposed metalworkers, NIOSH is concerned that  long-term exposure
to MWFs may cause chronic lung impairment in workers who experience acute
respiratory effects.
An opportunity exists to reduce respiratory conditions in the many thousands of
metalworkers exposed to MWF aerosol concentrations greater than the REL by
reducing exposures to below the REL.  The onset or worsening of many symp-
toms over a work-shift, as well as reported substantial symptomatic improvement
experienced by many affected workers when away from work, suggest opportuni-
ties not only for reversing early MWF-induced airways effects, but also for pre-
venting chronic effects induced by occupational exposure to MWF aerosol,
through control of worker exposure to MWF aerosols.
The recent decline in worker MWF exposure levels suggests that
developed control technologies can significantly reduce exposure
concentration levels.
Major changes introduced into the U.S. machine tool industry over the last several
decades have increased the overall consumption of MWFs.  Specifically, the use
of synthetic MWFs increased as tool and cut speeds increased.  At the same time,
technological advances allowed the partial enclosure of machines and the applica-
tion and use of  local exhaust ventilation.  During the 1970s and 1980s, many U.S.
plants installed recirculating air cleaners, improved the recirculating air filtration
systems, and renovated the factories.
In the automotive industry these changes resulted in a significant decline in
worker exposures to airborne MWFs over a 30-year period (1958-1987).  Since
1987, the exposures in the automotive industry have continued to decline.  The
NIOSH health hazard evaluation (HHE) program (1972-1993) and the Integrated
Management Information System (IMIS) of OSHA have also reported decreases
worker exposure to airborne MWFs.  The trend of declining exposure concentra-
tions suggests that developed control technologies can significantly reduce expo-
sure concentration levels.
Poor Enclosures
Section 3 - Recommendations for an
Occupational Safety and Health Program
In addition to the REL, NIOSH recommends that employer’s develop and imple-
ment a comprehensive safety and health program as part of their management
system.  This program must have strong management commitment, worker in-
volvement, and include four major components: (1) safety and health training, (2)
worksite analysis, (3) hazard prevention and control, and (4) medical monitoring
of exposed workers.
1. Safety and Health Training
Employers should establish a safety and health training program for all workers
potentially exposed workers to MWFs. This training program should:
• enable workers to identify potential workplace hazards;
• inform employees and contract workers about any hazardous chemicals in




• provide information on material safety data sheets (MSDSs) and other
information sources;
• teach workers how to detect hazardous situations (e.g., appearance of
bacterial overgrowth and degradation of MWFs) and how they can protect
themselves (e.g., the use of appropriate work practices, emergency proce-
dures, and personal protective equipment); and,
• encourage workers to maintain good personal hygiene and housekeeping
practices to help prevent environmental contamination of the MWFs.
2. Worksite Analysis
An effective workplace monitoring program should include routine environmental
monitoring of dermal and inhalation exposures.  Environmental monitoring and
sampling can help assess the effectiveness of engineering controls, work practices,
and personal protective equipment and help determine the likelihood that a work-
place exposure caused the worker’s symptoms.
The initial environmental sampling survey should use personal sampling tech-
niques for the entire work shift, concentrating on work areas where airborne
MWF exposures may occur.   Each survey should evaluate the workers’ potential
skin exposures and all routine personal samples (including samples representative
of the full-shift time-weighted average exposure to airborne MWFs) should be
collected in the worker’s breathing zone.  Few full-shift samples, if any, should
exceed the recommended exposure limit.
Each exposure measurement should represent actual worker exposure.  Periodic
sampling of all workers or worker groups will ensure that the targeted sampling
includes all workers with exposure potentials above the REL.  Conduct airborne
exposure measurements at least every six months for workers with exposure
levels at or above one-half of the REL, or more frequently as indicated by an
industrial hygienist.  Notify workers of the results of all sampling and increase
monitoring of exposed workers until at least two samples indicate that the expo-
sure no longer exceeds the REL.  Notify workers of additional monitoring and
explain control actions taken to reduce their exposures.
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Fluid Filter
3. Hazard Prevention and Control
Proper MWF selection and application, fluid maintenance, isolation of the
operation(s), ventilation, and other operational procedures can prevent or mini-
mize inhalation of MWF aerosols.  Dermal exposures may be reduced by the use
of machine guarding and protective equipment such as gloves, face guards,
aprons, or other protective work clothes.
Fluid Selection
The MWFs selected should be as nonirritating and nonsensitizing as possible
while remaining consistent with operational requirements.  Petroleum-containing
MWFs should be evaluated for potential carcinogenicity using ASTM Standard
D1687-95, Determining Carcinogenic Potential of Virgin Base Oils in Metalwork-
ing Fluids.  If soluble oils or synthetic fluids are used, ASTM Standard E1497-94,
Safe Use of Water-Miscible Metalworking Fluids should be consulted for safe-use
guidelines, including product selection, storage, dispensing, and maintenance.  To
minimize the potential for nitrosamine formation, nitrate-containing materials
should not be added to MWFs containing ethanolamines.
Fluid Use and Application
Many factors influence the generation of MWF mists, which can be minimized
through the proper design and operation of the MWF delivery system.  ANSI
Technical Report B11 TR 2-1997 (Mist Control Considerations for the Design,
Installation and Use of Machine Tools Using Metalworking Fluids) [ANSI 1997],
provides directives for minimizing mist and vapor generation.  These include
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minimizing fluid delivery pressure, matching the fluid to the application, using
MWF formulations with low oil concentrations, avoiding contamination with
tramp oils, minimizing the MWF flow rate, covering fluid reservoirs and return
systems where possible, and maintaining control of the MWF chemistry.
Also, proper application of MWFs can minimize splashing and mist generation.
Proper application includes:
• applying MWFs at the lowest possible pressure and flow volume
consistent with provisions for adequate part cooling, chip removal, and
lubrication;
• applying MWFs at the tool/work piece interface to minimize contact with
other rotating equipment;
• ceasing fluid delivery when not performing machining;
• not allowing MWFs to flow over the unprotected hands of workers loading
or unloading parts; and,
• using mist collectors engineered for the operation and specific machine
enclosures.
Properly maintained filtration and delivery systems provide cleaner MWFs,
reduce mist, and minimize splashing and emissions.  Proper maintenance of the
filtration and delivery systems includes:
• the selection of appropriate filters;
• ancillary equipment such as chip handling operations, dissolved
air-flotation devices, belt skimmers, chillers or plate and frame heat
exchangers, and decantation tanks;
• guard coolant return trenches to prevent dumping of floor wash water and
other waste fluids;
• covering sumps or coolant tanks to prevent contamination with waste or
garbage (e.g., cigarette butts, food, etc.); and
• keeping the machine(s) clean of debris.
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Fluid Maintenance
A key element in controlling worker exposure to MWFs is the development of a
written MWF management plan.  Components of this plan should include mainte-
nance of the fluid chemistry as well as the fluid filtration and delivery systems.
Temperature
Store the drums, tanks, or other containers of MWF concentrates in an area that
will protect them from outdoor weather conditions and exposure to low or high
temperatures.  MWFs should be maintained at as low a temperature as is practical.
Low temperatures slow the growth of microorganisms, reduce water losses and
change in viscosity, and in the case of straight oils, reduce the fire hazard risks.
Extreme temperature changes may destabilize the fluid concentrates, especially
concentrate mixed with water, and cause water to seep into unopened drums
encouraging bacterial growth in the fluids.
Concentration Levels
Routinely monitor MWFs and keep records of the fluid levels in the sump or
coolant tank, the MWF concentration (maintain within the pH and concentration
ranges recommended by the formulator or supplier), the fluid pH, and the degree
of tramp oil contamination (by visual inspection).  Increase testing during hot
weather or increased work output, both of which may result in increased fluid
losses.
To maintain proper MWF concentrations, do not top off with water or concentrate.
Rather, prepare the MWF emulsion by first adding the concentrate to the clean
water (in a clean container) and then adding the emulsion to the solution in the
coolant tank.  Mix the MWFs just before use and do not store large amounts
because of potential deterioration.
Personal Protective Clothing
Always wear personal protective clothing and use protective equipment when
removing concentrates from the original container, mixing and diluting MWF
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concentrate,  preparing additives (including biocides), and adding MWF emul-
sions, biocides or other potentially hazardous ingredients to the coolant reservoir.
Personal protective clothing includes eye protection or face shields, gloves, and
aprons which do not react with but rather shed MWF ingredients and additives.
Service
Regular service of coolant systems and maintenance of the machines will prevent
contamination of the fluids by tramp oils (e.g., hydraulic oils, gear box oils, and
machine lubricants leaking from the machines or total loss slideway lubrication).
Tramp oils can destabilize emulsions, cause pumping problems and clog filters.
Tramp oils can also float to the top of MWFs effectively sealing the fluids from
the air, allowing metabolic products (such as volatile fatty acids, mercaptols,
scatols, ammonia, and hydrogen sulfide) produced by the anaerobic and faculta-
tive anaerobic species growing within the biofilm to accumulate in the reduced
state.  A variety of methods can remove tramp oils, including: centrifugal liquid/
liquid separators, coalesces, oleophilic belts and ropes, skimmers, and vacuum.  In
work situations that involve high lubrication losses, consider the use of continu-
ous removal systems.
Thoroughly clean all parts of the system when replacing MWFs because microor-
ganisms grow on surfaces whenever possible.  Some bacteria, such as Pseudomo-
nas and Flavobacter species secrete layers of slime and may grow in stringy
configurations that resemble fungal growth.  Many bacteria secrete polymers of
polysaccharide and/or protein, forming a glycocalyx, which cements cells together
much as mortar holds bricks.  Fungi may grow as masses of hyphae, forming
mycelial mats.  This attached community of microorganisms appears as a biofilm
and may be very difficult to remove by ordinary cleaning procedures.  Cleaning
methods include: steam, vacuum, disinfectant solutions, or commercial chemical
cleaners.  Use a cleaning method compatible with the type of MWF.
Biocide Treatment
Biocides maintain the functionality and efficacy of MWFs by preventing micro-
bial overgrowth.  Biocides with a wide spectrum of biocidal activity should be
used to suppress the growth of the widely diverse contaminant population.  Only
Exhaust Air Recirculation
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the concentration of biocide needed to meet fluid specifications should be used,
since overdosing could lead to skin or respiratory irritation in workers, and
under-dosing could lead to an inadequate level of microbial control.
Isolation
Isolation of the worker through mechanical parts handling equipment and machine
enclosures can minimize skin and inhalation exposure.  Simple splash guarding
may suffice for low production machines.  While high production machines
require complete enclosure (with ventilation).  Locate transfer machines away
from other operations and protect workers with isolation booths or fresh air
showers.
Ventilation Systems
The ventilation system should be designed and operated to prevent the accumula-
tion or recirculation of airborne contaminants in the workplace.  The following
publications present general principles for the design and operation of ventilation
systems:
Industrial Ventilation:  A Manual of Recommended Practice;
American National Standard: Fundamentals Governing the Design and
Operation of Local Exhaust Systems; and
Recommended Industrial Ventilation Guidelines.
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OEM Enclosure
Exhaust ventilation systems function through suction openings placed near a
source of contamination.  The suction opening or exhaust hood creates an air
motion sufficient to overcome room air currents and any airflow generated by the
process.  This airflow captures the contaminants and conveys them to a point
where they can either be discharged or removed from the airstream.  Exhaust
hoods are classified by their position relative to the process as canopy, side draft,
down draft or enclosure.  ANSI Technical Report B11 TR 2-1997 [ANSI 1997]
contains guidelines for exhaust ventilation of machining and grinding operations.
Enclosures are the only type of exhaust hood recommended by the ANSI commit-
tee.  They consist of physical barriers between the process and the worker’s
environment.  Enclosures can be further classified by the extent of enclosure:
close capture (enclosure of the point of operation), total enclosure (enclosure of
the entire machine), or tunnel enclosure (continuous enclosure over several
machines).
If no fresh make up air is introduced into the plant, air will enter the building
through open doors and windows, potentially causing cross-contamination of all
process areas.  Ideally, all air exhausted from the building should be replaced by
tempered air from an uncontaminated location.  By providing a slight excess of
make up air in relatively clean areas and a slight deficit of make up air in dirty
areas, cross-contamination can be reduced.  In addition, this air can be channeled
directly to operator work areas, providing the cleanest possible work environment.
Ideally, this fresh air should be supplied in the form of a low-velocity air shower

























Effectiveness of Machine Enclosures
Protective Clothing and Equipment
Engineering controls are used to reduce worker exposure to MWFs.  But in some
situations, the added protection of chemical protective clothing (CPC) and respira-
tors should be provided in the event of dermal contact with the MWFs or airborne
exposures that exceed the REL.  Maintenance staff may also need CPC because
the nature of the work requires contact with MWFs during certain operations. All
workers should be trained in the proper use and care of CPC.  After any item of
CPC has been in routine use, it should be examined to ensure that its effectiveness
has not been compromised.
If respiratory protection is needed, the employer should establish a comprehensive
respiratory protection program as outlined in the NIOSH Respirator Decision
Logic  and the NIOSH Guide to Industrial Respiratory Protection a d as required
in the OSHA respiratory protection standard. Respirators should be selected by
the person who is in charge of the program and knowledgeable about the work-
place and the limitations associated with each type of respirator.
Selection of the appropriate respirator depends on the operation, MWF chemical
components, and airborne concentrations of MWFs in the worker’s breathing





Workers should keep personal items such as food, drink, cosmetics, and tobacco
separate from the work environment to prevent any unnecessary additional expo-
sures to MWFs.  Employers should establish a  “no smoking” policy because
cigarette smoke may exacerbate the respiratory effects of MWF aerosols.
Training and instruction in personal hygiene will help reduce potential dermal
MWF exposures.  Workers should promptly clean exposed skin contaminated
with MWFs with gentle soaps, clean water, and clean towels, and should change
from contaminated work clothes into street clothes before leaving work.  If pos-
sible, workers should shower and change into clean clothes at the end of the work
shift.
Keep the floors, equipment and general work environment clean.  Do not dump or
sweep wastes, including floor wash water, into MWF sumps or coolant return
trenches.
Labeling and Posting
Employers should train workers on OSHA Hazard Communication labeling
standards.  Labels must inform workers of chemical exposure hazards,  potential
adverse health effects, and appropriate methods for self-protection.  Post labels
and signs on, or near, hazardous metalworking processes to provide an initial
warning to other workers who may not routinely work near the processes and
transient nonproduction workers.  Depending on the process and exposure con-
centration, warning signs should state a need to wear protective clothing or an
appropriate respirator for regular exposure to MWF aerosol greater than the REL.
Post all labels and warning signs in both English and the predominant language of
workers who do not read English.
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4. Medical Monitoring of Exposed Workers
As indicated by the research, the 0.4-mg/m3 (thoracic particulate mass) REL for
MWF aerosol does not remove all risk for the development of skin or respiratory
disease among exposed workers.  Medical monitoring is therefore needed for
early identification of workers who develop symptoms of MWF-related conditions
such as asthma, HP, and dermatitis.  If identified early, affected workers can
control their exposures and minimize their risks of acute or chronic effects.
Another important objective of medical monitoring is to provide standardized data
on exposed workers to identify work areas in need of additional primary preven-
tion efforts.
All exposed workers should be included in an occupational medical monitoring
program.  However, priority should be given to those at highest risk.   Medical
monitoring should be conducted regardless of exposure concentration in work
areas where one or more workers have recently developed asthma, HP, or other
serious conditions apparently related to MWF exposure.
The medical monitoring program should provide all workers with information
about the purposes of the program, the potential health-protection benefits of
participation, and a description of the procedural aspects of the program.  This
information should include the use of routine test results, potential actions based
on these results, who has access to individual results of routine medical monitor-
ing and of more detailed medical evaluations, and how confidentiality is main-
tained.
A qualified physician (or other qualified health care provider as determined by
appropriate state laws and regulations), informed and knowledgeable about the
following, should direct and supervise the medical monitoring program:
• the respiratory protection program and types of personal respiratory pro-
tection devices available at the workplace,
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• the identification and management of occupational asthma and other
work-related respiratory effects or illnesses (including preexisting asthma
exacerbated by occupational exposures), and
• the identification and management of occupational skin diseases.
Information Pr ovided to Program Supervisor/Director
The employer should provide the supervisor/director with specific information for
each worker covered by the medical monitoring program.  This information
should include current and previous job assignments/descriptions, potential
hazardous exposures, actual exposure measurements, personal protective equip-
ment provided/used, relevant material safety data sheets, and applicable occupa-
tional safety and health standards.  If a worker is referred to others for either
periodic examinations or detailed evaluations, the initial examiner should provide
the appropriate information to all future examiners.
Initial or Pr eplacement Examination
Each worker included in the medical monitoring program should receive an initial
medical examination.  For newly hired workers and workers transferred from an
unexposed work area, this examination should occur before assignment to a job
associated with exposure to MWFs or MWF aerosols.  At a minimum, the initial
examination should consist of a standardized questionnaire to obtain information
concerning medical history (of asthma, other serious respiratory conditions, and
skin diseases) and an examination of the skin.  Baseline spirometric testing may
also prove useful for comparisons with subsequent tests in individual workers.
Periodic Examination
All workers included in the medical monitoring program should undergo periodic
screening examinations based on the frequency and severity of health effects in
the specific worker population.  These examinations should include a brief stan-
dardized questionnaire that ascertains the presence or absence of symptoms
indicative of possible respiratory conditions (e.g., episodic shortness of breath,
wheeze, chest tightness, or cough) and skin disorders, as well as their temporal
relationship to work.  Also determine the use of medications for these conditions.
If resources permit, routine periodic examinations should include examination of
the skin and spirometric testing.  The skin examination should emphasize dermati-
tis and nonmelanoma cancer.  The addition of spirometric testing will improve the
sensitivity and specificity of screening programs.  The spirometric testing should
emphasize measurement of forced expiratory volume in one second (FEV1) and
forced vital capacity (FVC).  Conduct spirometry both preshift (on the first day
back to work after a weekend off) and postshift on the same day.  Then, interpret
each worker’s preshift values with respect to predicted normal values, as well as
in comparison to that same worker’s previous test results, and evaluate cross-shift
differences for indication of an acute adverse effect of work exposure.  Such
objective examination and testing complements information obtained from ques-
tionnaires.
Detailed Medical Examination for Selected Workers
Any worker should undergo more frequent medical evaluations if:  (1)  identified
by periodic questionnaire, spirometry testing, or self-referral as having respiratory
symptoms or physiologic effects suggesting asthma and/or other respiratory
condition possibly related to MWF aerosol exposure; (2) identified by periodic
questionnaire, skin examination, or self-referral as having recurrent or chronic
dermatitis; or (3) judged by the program director/supervisor to have any medically
significant reason for more detailed assessment.
Detailed pulmonary evaluations should include a careful history and the appropri-
ate physiological testing.  Use physiological testing to document/confirm
hyperresponsive airways (e.g., a comparison of pre- and postbronchodilator
spirometry, and/or methacholine challenge testing) and more specifically to
document airway effects associated with workplace exposure to MWF aerosols
(e.g., a comparison of pre- and postshift spirometry testing on the first day of the
workweek and/or serial peak flow testing over several days).  Allow highly spe-
cialized laboratories and experienced clinical investigators to perform
laboratory-based specific inhalation challenge testing .
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Dermatological evaluations should include a full medical and occupational his-
tory, a medical examination, a review of exposures, possibly diagnostic tests (such
as skin patch tests to detect causes of allergic contact dermatitis), and complete
follow-up to note the progress of the individual.
Physician’s Reports to the Worker
Following the initial and each periodic or detailed examination, the physician
should provide a written report to the worker.  This report should include the
following:
• the results of any medical tests performed on the worker,
• the  physician’s opinion about any medical conditions that would increase
the worker’s risk of impairment from exposure to MWF or MWF aerosols
(or any other agents in the workplace),
• the physician’s recommended limits on the worker’s exposure to MWF or
MWF aerosols (or any other agents in the workplace) and on the worker’s
use of respiratory protective devices and/or protective clothing, and
• the physician’s recommendations about further evaluation and treatment of
any detected medical conditions.
Physician’s Reports to the Employer
Following the initial and each periodic or detailed examination, the physician
should provide a written report to the employer.  This report should include the
following:
• the physician’s recommended limits on the worker’s exposure to MWF
aerosols (or any other agents in the workplace) and on the worker’s use of
personal respiratory protective devices and/or protective clothing, and
• a statement that the worker has been informed of the results of the medical
examination and of any medical condition(s) that should have further
evaluation and/or treatment.
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To protect confidentiality, the report provided to the employer should not reveal
specific findings or diagnoses without a signed authorization from the worker.
Follow-Up Medical Evaluations
Reevaluate workers transferred as a result of the physician’s opinion to document
the achievement of the intended benefit (e.g., reduced symptoms and/or reduced
physiologic effects).  Continue to monitor transferred workers periodically until
they have not shown symptoms for at least two years.
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